Pharmaceutical development has never lacked ambition. What it frequently lacks, however, is time.
Turning a validated scientific concept into an execution-ready protocol remains a major obstacle in pharmaceutical R&D.
This process can require reviewing prior research, gathering and analyzing data, determining study feasibility, assessing potential sites, considering compliance criteria, and coordinating reviews across multiple teams.
When these stages depend on disconnected systems, manual handoffs, and unconnected data from both laboratory and clinical settings, initiating a study can take weeks or even months.
The goal is not to replace the intuition of a scientist, but to remove the operational noise that currently consumes their time.”
Historical trial data may live in one system, while scientific literature lives elsewhere. Regulatory guidance can be spread across multiple documents, and operational knowledge regarding recruitment, site performance, or study feasibility may rely on the experience of individual team members.
The same challenge can exist within lab workflows. Method information, analytical results, supporting documentation, source data, and sample context may be distributed across LIMS, ELN, SDMS, and other connected or disconnected systems.
The protocol serves as the operational plan for performing a clinical trial. Inadequately defined inclusion criteria, misaligned endpoints, insufficient sampling approaches, or unresolved site-feasibility problems can create a cascade of challenges later in the study.
What does agentic AI change?
Agentic AI is not merely another chatbot or text-generation tool. Rather, it is engineered to pursue a goal by breaking work into coordinated steps across data, systems, and workflows.
In pharmaceutical R&D, this could include helping scientists retrieve relevant prior studies, synthesize evidence from approved resources, compare dosing regimens, assess potential research sites, and flag operational risks before a clinical trial is completed.
Rather than automating scientific decision-making, agentic AI aims to minimize the hands-on effort required to assemble, reconcile, and review the data supporting those decisions.
Automation vs. orchestration
Conventional automation is extremely effective for defined, repeatable tasks. Agentic AI may expand those capabilities by coordinating multi-step work across data sources.
In practice, this could involve combining protocol inputs, lab sample context, feasibility information, controlled documents, and historical study data. The AI-enabled workflow could then prepare source-linked summaries, draft materials, or recommendations for qualified experts to review.
Such orchestration would help an organization to advance beyond the pilot stage of AI. Instead of adding yet another isolated system, organizations can use it for repeatable processes to streamline review efforts.
Maintaining control in a faster process
In life sciences, acceleration cannot compromise control. Qualified specialists must also remain accountable for the decisions that follow.
In practice, governed AI means designing AI-enabled workflows with:
- Traceable sources: Outputs are connected to approved source materials, relevant sample or study context, and supporting data.
- Controlled data access: Role-based access ensures users and AI workflows interact only with the appropriate data and documents.
- Documented workflow steps: Connected LIMS, ELN, SDMS, and related environments capture actions, handoffs, and changes.
- Human approval checkpoints: Researchers, clinicians, and other qualified specialists review and approve recommendations at defined decision points.
- Auditable outputs: A system of record retains recommendations, approvals, and supporting evidence to facilitate review and inspection readiness.
In agentic workflows, traceability is not an add-on; it is what enables experts to validate, approve, and stand behind the outcome.”
Governance can become a competitive advantage
Although governance enables compliance and trust, its true value lies beyond that.
By implementing well-defined controls for access, data provenance, approval, and auditing, organizations can reduce the friction that often impedes AI solution deployment after the first pilot.
This means that organizations can realize substantial business benefits through faster implementation in R&D departments, fewer review cycles, improved inspection readiness, and greater success in scaling intelligent processes.
Rather than treating each AI solution as an isolated experiment, the organization can develop a repeatable process that incorporates intelligence into activities such as protocol development, laboratory work, and study start-up.
Keep scientists in the driver’s seat
Agentic AI is designed to protect clinical and scientific experts, not replace them. It can add value through data collection, evidence documentation, workflow coordination, and the presentation of evidence through connected systems.
AI can do the operational heavy lifting. Experts still lead the strategy and remain accountable for the decisions.”
AI’s place in R&D has already been established. The question is now whether it is governed, integrated, and ready to create value at scale.
LabVantage’s article, ‘Future-Proofing Life Sciences: The Strategic Imperative of Agentic AI in R&D,’ examines how governed agentic AI may help organizations accelerate protocol design and research start-up activities.
For more information on how LabVantage CORTEX™ offers a potential opportunity and emphasizes how results will vary according to data quality, integration, governance, workflow maturity, and implementation scope, visit LabVantage.
About LabVantage Solutions 
LabVantage Solutions is a global leader in laboratory informatics, helping laboratories accelerate digital transformation and unlock greater value from scientific data. LabVantage CORTEX™ is the company’s AI, analytics, and automation platform, bringing laboratory data and workflows together in one intelligent environment. The 100% browser-based platform integrates LIMS, ELN, LES, SDMS, analytics, and Agentic AI to help organizations streamline laboratory operations, connect data across workflows, and make more informed data-driven decisions from a unified environment.
With more than 40 years of LIMS expertise and over 1,500 customers across industries, LabVantage supports laboratories in pharmaceuticals, biotechnology, diagnostics, food and beverage, chemicals, forensics, contract testing, and research. LabVantage combines deep laboratory domain knowledge with configurable technology and global services to help customers improve process efficiency, strengthen data integrity, and support quality and compliance requirements.
LabVantage CORTEX™ is designed for responsible use in laboratory environments, with human-in-the-loop governance, approval workflows, and audit trails that make AI-assisted activities transparent and reviewable. This allows laboratories to apply AI and automation with confidence while maintaining the controls needed in regulated and quality-focused settings.
Headquartered in Somerset, New Jersey, LabVantage serves customers worldwide through global teams, regional offices, and partners. Learn more at labvantage.com.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.net, which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.